Save time and get answers to complex questions with AI chat
Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?What is the difference between apixaban and apixaban accord?What's the advised delay for milk post lipitor?What is dabrafenib mesylate msn patent issue?Drugpatentwatch crizotinib?
See the DrugPatentWatch profile for polivy
What age range made up the majority of participants in polivy's clinical trials? Polivy is a medication used to treat cancer, specifically diffuse large B-cell lymphoma (DLBCL). According to the clinical trial results [1] on ClinicalTrials.gov, the majority of participants in the clinical trials for Polivy (polaratumab) were within the age range of 18-64 years. A clinical trial conducted on 305 adults suffering from heavily pretreated diffuse large B-cell lymphoma (DLBCL) reported that the median age of participants was 65 years, with a range of 18-93 years [2].
Other Questions About Polivy :